Cargando…
Tetrahydrobiopterin Improves Endothelial Function in Cardiovascular Disease: A Systematic Review
Background. Tetrahydrobiopterin (BH(4)) is a cofactor of nitric oxide synthase (NOS). Nitric oxide (NO) bioavailability is reduced during the early stage of vascular diseases, such as coronary artery disease, hypercholesterolemia, hypertension, and diabetic vasculopathy, and even throughout the enti...
Autores principales: | Wang, Qiongying, Yang, Mina, Xu, Han, Yu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273464/ https://www.ncbi.nlm.nih.gov/pubmed/25548592 http://dx.doi.org/10.1155/2014/850312 |
Ejemplares similares
-
Role for Tetrahydrobiopterin in the Fetoplacental Endothelial Dysfunction in Maternal Supraphysiological Hypercholesterolemia
por: Leiva, Andrea, et al.
Publicado: (2016) -
A key role for tetrahydrobiopterin‐dependent endothelial NOS regulation in resistance arteries: studies in endothelial cell tetrahydrobiopterin‐deficient mice
por: Chuaiphichai, Surawee, et al.
Publicado: (2017) -
Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis
por: Mäki‐Petäjä, Kaisa M., et al.
Publicado: (2016) -
Dexamethasone, tetrahydrobiopterin and uncoupling of endothelial nitric oxide synthase
por: Tobias, Silke, et al.
Publicado: (2015) -
A novel role for endothelial tetrahydrobiopterin in mitochondrial redox balance
por: Bailey, Jade, et al.
Publicado: (2017)